- Revenue Growth: $266.8 million in Q2 2026, up nearly 20% year-over-year.
- Order Backlog Surge: Total orders jumped 40% to $291 million, with organic growth at 10%.
- Nuclear Market Expansion: Global nuclear power capacity projected to grow from 443 GW (2025) to over 520 GW by 2035.
Experts would likely conclude that Mirion Technologies is strategically well-positioned to capitalize on the global nuclear power revival, supported by strong financial performance and a robust backlog of orders.
Mirion Technologies: Riding the Wave of a Global Nuclear Power Revival
ATLANTA, GA – July 28, 2026 – In a world grappling with the dual challenges of energy security and decarbonization, the once-sidelined nuclear power industry is experiencing a powerful renaissance. Few companies are better positioned to both enable and benefit from this shift than Mirion Technologies (NYSE: MIR). The radiation safety and measurement specialist just posted strong second-quarter 2026 results, demonstrating not just financial health, but the successful execution of a strategy aimed squarely at the heart of the revitalized nuclear sector.
Mirion's latest earnings release paints a picture of a company hitting its stride. It reported expanded margins, growing cash flow, and a burgeoning backlog of orders. Crucially, it reaffirmed its ambitious full-year guidance for 2026, a clear signal of confidence from management that the tailwinds pushing its business are both strong and sustainable. This performance isn't just about numbers on a spreadsheet; it's a reflection of deeper systemic changes in how we plan to power and protect our future.
Powering the Nuclear Renaissance
The most compelling part of Mirion's story is its deep integration with the expanding nuclear power market. “Our acquisitions of Certrec and Paragon have augmented our ability to capitalize on growing nuclear power opportunities in North America,” CEO Thomas Logan stated in the announcement. This is more than standard corporate optimism; it’s a direct acknowledgment of a calculated bet on a global megatrend.
The numbers support this wager. The global nuclear power market is projected to grow from roughly 443 gigawatts (GW) in 2025 to over 520 GW by 2035. This growth is driven by a confluence of factors: government policies prioritizing energy independence, the extension of existing reactor lifespans, and the development of next-generation technologies like Small Modular Reactors (SMRs). A surprising new catalyst has also emerged: the voracious energy appetite of the artificial intelligence industry. In 2026 alone, major tech firms have reportedly contracted for nearly 10 GW of future nuclear power capacity to run their data centers on a carbon-free basis.
Mirion's recent acquisitions have sharpened its competitive edge in this environment. The purchase of Certrec, a key provider of regulatory compliance services to every nuclear reactor in the U.S., gives Mirion a crucial, embedded role in the operational fabric of the industry. The acquisition of Paragon Energy Solutions, which saw its own revenue jump 45% in the first quarter, further expands Mirion's footprint, particularly in servicing the massive installed base of existing reactors. As one analyst noted, these moves allow the company to offer solutions across the “cradle-to-grave lifespan of a modern large-scale reactor,” creating a deeply entrenched and recurring revenue model.
A Financial Snapshot of Confidence
While the strategic narrative is compelling, the financial metrics provide the grounding. Mirion delivered second-quarter revenue of $266.8 million, a nearly 20% increase over the same period last year. More impressively, its adjusted earnings per share (EPS) of $0.12 beat analyst expectations by 20%, demonstrating strong profitability. Adjusted EBITDA, a key measure of operational performance, surged over 27% to $65.3 million.
Perhaps the most significant forward-looking indicator is the company's order book. Total orders, bolstered by its recent acquisitions, soared 40% to $291 million. Even on a purely organic basis, orders grew by a healthy 10%. This influx of new business is building a robust backlog that provides strong visibility into future revenue streams.
This operational strength is what gives the company the confidence to reaffirm its full-year guidance for 2026. Mirion still expects total revenue to grow between 22% and 24%, with adjusted EBITDA landing between $285 million and $300 million. This steadiness in the face of global economic crosscurrents underscores management’s belief that its core markets, particularly nuclear, are on a solid upward trajectory. The company is signaling that it has the strategy, the technology, and the market position to deliver on its promises through the second half of the year and beyond.
Beyond Energy: A Dual Mandate in Safety and Medicine
While the nuclear energy story dominates the headlines, it represents only one facet of Mirion's complex and vital role. The company operates across a diverse set of end markets, all revolving around the safe measurement and application of ionizing radiation. Its business is fundamentally a system of trust, providing the validated, compliant, and precise tools necessary for critical work in defense, research, and medicine.
The Mirion Medical group is a key pillar of this mission. Its technologies are essential for ensuring safety and efficacy in fields like nuclear medicine, diagnostic imaging, and radiation therapy. The company's equipment is found in 80% of cancer centers worldwide, playing a quiet but indispensable role in patient care. The 2023 acquisition of Landauer significantly bolstered its capabilities in personal dosimetry, the science of monitoring radiation exposure for healthcare and industrial workers.
In its earnings report, Mirion noted it was “adjusting the end-market composition of our Medical segment” within its guidance. While specific details were not provided, this points to the dynamic nature of the healthcare technology landscape and the company's continuous effort to optimize its portfolio. For investors and observers, it highlights an area to watch as the company refines its focus in this critical sector.
Ultimately, Mirion's performance serves as a barometer for broader shifts in our global infrastructure. Its success is tethered to our collective push for cleaner energy, our advancements in complex medical treatments, and our unwavering need for safety and security in an increasingly technological world. The company isn’t just selling detectors and software; it’s providing the essential measurement systems that allow these massive, complex industries to function safely and grow with confidence.
Topics & Related
Nuclear
Nuclear Renaissance
Quarterly Earnings
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →